The Liofilchem® Clindamycin CD Antimicrobial Susceptibility Discs are high-quality, standardized paper discs impregnated with Clindamycin at concentrations of 2 µg and 10 µg. These discs are designed for antibiotic susceptibility testing (AST) in clinical and research laboratories to evaluate the sensitivity of bacterial pathogens to Clindamycin, a lincosamide antibiotic.
Key Features
1. Multiple Concentrations
- Available in 2 µg and 10 µg:
- 2 µg: Commonly used for routine AST.
- 10 µg: Suitable for specific high-dose therapeutic scenarios or resistance profiling.
2. High Sensitivity and Specificity
- Accurately determines susceptibility or resistance in Gram-positive bacteria, including:
- Staphylococcus aureus (including MRSA strains).
- Streptococcus spp..
- Anaerobic pathogens.
3. Compliance with International Standards
- Meets guidelines from EUCAST, CLSI, and ISO for standardized AST.
- Delivers reproducible results for clinical diagnostics and research.
4. Precision and Quality
- Manufactured under strict quality control for uniform drug diffusion and reliable performance.
5. Easy Integration
- Compatible with standard Kirby-Bauer disc diffusion methods, making it suitable for routine use in clinical microbiology labs.
Applications
1. Clinical Diagnostics
- Assess bacterial susceptibility to Clindamycin for guiding treatment of infections such as:
- Skin and soft tissue infections.
- Bone and joint infections.
- Respiratory tract infections.
2. Detection of Inducible Resistance
- Use in conjunction with erythromycin discs to perform the D-test for detecting inducible clindamycin resistance in Staphylococcus aureus and Streptococcus spp.
3. Resistance Monitoring
- Monitor trends in Clindamycin resistance among clinical isolates, particularly in methicillin-resistant Staphylococcus aureus (MRSA).
4. Research and Development
- Investigate the efficacy of Clindamycin in experimental studies or assess resistance mechanisms.
Specifications
| Parameter | Details |
|---|---|
| Antibiotic | Clindamycin (CD) |
| Disc Concentrations | 2 µg, 10 µg |
| Target Organisms | Gram-positive and anaerobic bacteria |
| Compliance | EUCAST, CLSI, ISO standards |
| Shelf Life | Refer to product label |
| Storage Conditions | 2–8°C / -20°C |
Advantages
1. High Sensitivity
- Provides accurate susceptibility testing for a wide range of bacterial pathogens.
2. Precision
- Uniform drug diffusion ensures reproducible and reliable results.
3. Cost-Effective
- Ideal for high-throughput testing in clinical laboratories.
4. Versatility
- Suitable for detecting both constitutive and inducible resistance.
How It Works
- Inoculate Plate:
- Spread a standardized bacterial suspension (e.g., 0.5 McFarland) onto a Mueller-Hinton agar plate.
- Apply Discs:
- Place Clindamycin discs (2 µg or 10 µg) on the agar surface.
- Incubation:
- Incubate the plate at 35–37°C for 16–18 hours.
- Result Interpretation:
- Measure the diameter of the zone of inhibition and interpret results using CLSI or EUCAST breakpoints.
Why Choose Liofilchem® Clindamycin Discs?
- Standardized Testing: Ensures reliable and reproducible results.
- Versatile Applications: Effective for detecting Clindamycin resistance and guiding therapy.
- High Quality: Manufactured to strict standards for consistent performance.
The Liofilchem® Clindamycin CD Antimicrobial Susceptibility Discs (2 µg, 10 µg) are essential tools for evaluating bacterial susceptibility to Clindamycin, supporting effective treatment decisions and antimicrobial resistance monitoring.
No resources are currently available for this product.
The Liofilchem® Clindamycin CD Antimicrobial Susceptibility Discs are high-quality, standardized paper discs impregnated with Clindamycin at concentrations of 2 µg and 10 µg. These discs are designed for antibiotic susceptibility testing (AST) in clinical and research laboratories to evaluate the sensitivity of bacterial pathogens to Clindamycin, a lincosamide antibiotic.
Key Features
1. Multiple Concentrations
- Available in 2 µg and 10 µg:
- 2 µg: Commonly used for routine AST.
- 10 µg: Suitable for specific high-dose therapeutic scenarios or resistance profiling.
2. High Sensitivity and Specificity
- Accurately determines susceptibility or resistance in Gram-positive bacteria, including:
- Staphylococcus aureus (including MRSA strains).
- Streptococcus spp..
- Anaerobic pathogens.
3. Compliance with International Standards
- Meets guidelines from EUCAST, CLSI, and ISO for standardized AST.
- Delivers reproducible results for clinical diagnostics and research.
4. Precision and Quality
- Manufactured under strict quality control for uniform drug diffusion and reliable performance.
5. Easy Integration
- Compatible with standard Kirby-Bauer disc diffusion methods, making it suitable for routine use in clinical microbiology labs.
Applications
1. Clinical Diagnostics
- Assess bacterial susceptibility to Clindamycin for guiding treatment of infections such as:
- Skin and soft tissue infections.
- Bone and joint infections.
- Respiratory tract infections.
2. Detection of Inducible Resistance
- Use in conjunction with erythromycin discs to perform the D-test for detecting inducible clindamycin resistance in Staphylococcus aureus and Streptococcus spp.
3. Resistance Monitoring
- Monitor trends in Clindamycin resistance among clinical isolates, particularly in methicillin-resistant Staphylococcus aureus (MRSA).
4. Research and Development
- Investigate the efficacy of Clindamycin in experimental studies or assess resistance mechanisms.
Specifications
| Parameter | Details |
|---|---|
| Antibiotic | Clindamycin (CD) |
| Disc Concentrations | 2 µg, 10 µg |
| Target Organisms | Gram-positive and anaerobic bacteria |
| Compliance | EUCAST, CLSI, ISO standards |
| Shelf Life | Refer to product label |
| Storage Conditions | 2–8°C / -20°C |
Advantages
1. High Sensitivity
- Provides accurate susceptibility testing for a wide range of bacterial pathogens.
2. Precision
- Uniform drug diffusion ensures reproducible and reliable results.
3. Cost-Effective
- Ideal for high-throughput testing in clinical laboratories.
4. Versatility
- Suitable for detecting both constitutive and inducible resistance.
How It Works
- Inoculate Plate:
- Spread a standardized bacterial suspension (e.g., 0.5 McFarland) onto a Mueller-Hinton agar plate.
- Apply Discs:
- Place Clindamycin discs (2 µg or 10 µg) on the agar surface.
- Incubation:
- Incubate the plate at 35–37°C for 16–18 hours.
- Result Interpretation:
- Measure the diameter of the zone of inhibition and interpret results using CLSI or EUCAST breakpoints.
Why Choose Liofilchem® Clindamycin Discs?
- Standardized Testing: Ensures reliable and reproducible results.
- Versatile Applications: Effective for detecting Clindamycin resistance and guiding therapy.
- High Quality: Manufactured to strict standards for consistent performance.
The Liofilchem® Clindamycin CD Antimicrobial Susceptibility Discs (2 µg, 10 µg) are essential tools for evaluating bacterial susceptibility to Clindamycin, supporting effective treatment decisions and antimicrobial resistance monitoring.
No resources are currently available for this product.
Specifications
| Drug Concentration | 2 µg, 10 µg |